Aardvark Therapeutics Appoints David Zhang as Class II Director
Position
Director
Company
Aardvark Therapeutics
Description
On October 6, 2026, Aardvark Therapeutics appointed David (Zhongwei) Zhang, Ph.D., MBA, as a Class II director of the company, effective October 7, 2026. Dr. Zhang brings over 25 years of experience in clinical program design and regulatory submissions
Quick answer
Aardvark Therapeutics Appoints David Zhang as Class II Director (October 8, 2026). Aardvark Therapeutics is based in San Diego, California, United States.
- What did Aardvark Therapeutics announce on October 8, 2026?
- On October 6, 2026, Aardvark Therapeutics appointed David (Zhongwei) Zhang, Ph.D., MBA, as a Class II director of the company, effective October 7, 2026.
- Where did David Zhongwei Zhang, Ph.D., MBA work before joining Aardvark Therapeutics?
- David Zhongwei Zhang, Ph.D., MBA joins from Abivax S.A.
- What does Aardvark Therapeutics do?
- Aardvark Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, inflammation,...
- Where is Aardvark Therapeutics based?
- Aardvark Therapeutics is based in San Diego, California, United States.
- Which similar companies made leadership changes around the same time?
- Everest Medicines (October 9, 2026), TETRAPHARM (October 9, 2026), Jazz Pharmaceuticals plc (October 9, 2026) and Modern Chemistry Labs (MCL) (October 7, 2026) also announced leadership changes within 45 days of Aardvark Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Manufacturing and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Everest Medicines Appoints Lakshmi Srinivasan and Brandon Coder to Senior Roles (October 9, 2026)
- TETRAPHARM Appoints Rolf Sass Sørensen as Chief Executive Officer (October 9, 2026)
- Jazz Pharmaceuticals Announces Transition in Leadership (October 9, 2026)
- Modern Chemistry Labs Appoints Elizabeth Morris as Chief Executive Officer (October 7, 2026)
- Boston Scientific Appoints Joseph M. Fitzgerald as Chief Operating Officer (October 7, 2026)
- Nanalysis Scientific Corp. Appoints Philip Birkby as Interim Chief Financial Officer (October 5, 2026)
Who to call at Aardvark Therapeutics, and when
A new leader at Aardvark Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Aardvark Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aardvark Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aardvark Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aardvark Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Aardvark Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.